01 7Supprelin LA
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 88
2019 Revenue in Millions : 87
Growth (%) : 2
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 114
2020 Revenue in Millions : 88
Growth (%) : 30
Main Therapeutic Indication : Endocrinology
Currency : USD
2022 Revenue in Millions : 113
2021 Revenue in Millions : 114
Growth (%) : -1
Main Therapeutic Indication : Endocrinology
Currency : USD
2023 Revenue in Millions : 97
2022 Revenue in Millions : 113
Growth (%) : -14
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 86
2016 Revenue in Millions : 79
Growth (%) : 10
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 81
2017 Revenue in Millions : 86
Growth (%) : -6%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 87
2018 Revenue in Millions : 82
Growth (%) : 6
LOOKING FOR A SUPPLIER?
